|
C14ORF138 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.298500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.019700E-02 |
| Normal-vs-Stage2 |
5.194200E-01 |
| Normal-vs-Stage3 |
7.770400E-01 |
| Normal-vs-Stage4 |
2.977200E-01 |
| Stage1-vs-Stage2 |
5.300400E-01 |
| Stage1-vs-Stage3 |
2.724800E-01 |
| Stage1-vs-Stage4 |
1.187170E-01 |
| Stage2-vs-Stage3 |
7.759600E-01 |
| Stage2-vs-Stage4 |
2.829600E-01 |
| Stage3-vs-Stage4 |
4.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.175300E-03 |
| Normal-vs-AfricanAmerican |
2.081000E-01 |
| Normal-vs-Asian |
5.408200E-01 |
| Caucasian-vs-AfricanAmerican |
3.632400E-01 |
| Caucasian-vs-Asian |
1.235610E-02 |
| AfricanAmerican-vs-Asian |
8.498100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.696650E-03 |
| Normal-vs-Female |
5.209200E-01 |
| Male-vs-Female |
1.721880E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.618010E-01 |
| Normal-vs-Extreme_Weight |
7.499000E-03 |
| Normal-vs-Obese |
1.643800E-01 |
| Normal-vs-Extreme_Obese |
3.323800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.252000E-01 |
| Normal_Weight-vs-Obese |
8.105200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.315800E-01 |
| Extreme_Weight-vs-Obese |
3.035200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.260800E-01 |
| Obese-vs-Extreme_Obese |
9.337000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.159200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.917600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.164000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.408800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.306000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.623200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.119000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.606000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.664160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.119200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.99500000028519E-07 |
| Normal-VS-Type2 PRCC |
7.378200E-02 |
| Normal-VS-KIRP CIMP |
1.407750E-01 |
| Normal-VS-Unclassified PRCC |
7.331600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.85520529231098E-11 |
| Type1 PRCC-VS-KIRP CIMP |
7.90449999999998E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.495300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.154600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.456100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.349000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.266000E-01 |
| Normal-vs-N1 |
4.082000E-01 |
| Normal-vs-N2 |
6.422100E-02 |
| N0-vs-N1 |
2.406600E-01 |
| N0-vs-N2 |
1.930960E-01 |
| N1-vs-N2 |
1.238770E-01 |
|
|
